Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period

Journal of Critical Care

Volumn 29, Issue 5, 2014, Pages 728-732

  Mitaka, Chieko ^a,b   Fujiwara, Naoto ^b   Yamamoto, Mamoru ^b   Toyofuku, Takahiro ^a   Haraguchi, Go ^b   Tomita, Makoto ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Endotoxin; Polymyxin B immobilized fiber column hemoperfusion; Septic shock

Indexed keywords

ENDOTOXIN; METICILLIN; POLYMYXIN B;

ACHROMOBACTER XYLOSOXIDANS; ACINETOBACTER BAUMANNII; ADSORPTION COLUMN; ADULT; AGED; ANALYTICAL EQUIPMENT; APACHE; ARTICLE; BACTEROIDES FRAGILIS; BLOOD SAMPLING; CLINICAL ARTICLE; ENDOTOXIN DETECTION; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEMALE; HEMATOLOGY EQUIPMENT; HEMOPERFUSION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LIMULUS LYSATE TEST; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MORTALITY; PSEUDOMONAS AERUGINOSA; RADIAL ARTERY; RETROSPECTIVE STUDY; SEPTIC SHOCK; SERRATIA MARCESCENS; STENOTROPHOMONAS MALTOPHILIA; TREATMENT OUTCOME; TURBIDIMETRY; ADSORPTION; BLOOD; DETOXIFICATION; ISOLATION AND PURIFICATION; PROCEDURES; SHOCK, SEPTIC; TIME; VERY ELDERLY;

ADSORPTION; ADULT; AGED; AGED, 80 AND OVER; APACHE; ENDOTOXINS; FEMALE; HEMOPERFUSION; HUMANS; MALE; MIDDLE AGED; POLYMYXIN B; RADIAL ARTERY; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; SORPTION DETOXIFICATION; TIME FACTORS;

EID: 84906057009     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.03.031     Document Type: Article

References (29)

1. Aderem A., Ulevirch R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406:782-787.
2. Shoji H., Tani T., Hanasawa K., et al. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application. Ther Apher Dial 1998, 2:3-12.
3. Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 2003, 7:108-114.
4. Cruz D.N., Perazella M.A., Bellomo R., et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007, 11:R47.
5. Cruz D.N., Antonelli M., Fumagalli R., et al. Early use of polymyxin B hemoperfusion in abdominal septic shock, the EUPHAS randomized controlled trial. JAMA 2009, 301:2445-2452.
6. Mitaka C., Tsuchida N., Kawada K., et al. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock. Shock 2009, 32:478-483.
7. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
8. Knaus W.A., Zimmerman J.E., Wagner D.P., et al. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 1981, 9:591-597.
9. Salden H.J.M., Bas B.M. Endotoxin binding to platelets in blood from patients with a sepsis syndrome. Clin Chem 1994, 40:1575-1579.
10. Endo S., Inada K. Effects of endotoxin (LPS) on a living body (2). Med Postgrad 1992, 30:27-34. [in Japanese].
11. Oishi H., Takaoka A., Hatayama Y., et al. Automated amebocyte lysate (LAL) test for endotoxin analysis using a new toxinometer ET-201. J Parenter Sci Technol 1985, 39:194-200.
12. Kambayashi J., Yokota M., Sakon M., et al. A novel endotoxin-specific assay by turbidimetry with limulus amoebocyte lysate containing β-glucan. J Biochem Biophys Methods 1991, 22:93-100.
13. Kojima M., Sato N., Yaegashi Y., et al. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Ther Apher Dial 2006, 10:12-18.
14. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock 2008.
15. Oudemans-van Straaten, Wester J.P.J., de Pont A.C.J.M., et al. Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?. Intensive Care Med 2006, 32:188-201.
16. Fiore G.B., Soncicni M., Vesentini S., et al. Multiscale analysis of the Toraymyxin adsorption cartridge. Part II: computational fluid-dynamic study. Int J Artif Organs 2006, 29:251-260.
17. Tani T., Chang T.M.S., Kodama M., et al. Endotoxin removed from hemoglobin solution using polymyxin-B immobilized fiber (PMX-F) followed by a new turbidometric endotoxin assay. Biomater Artif Cells Immobilization Biotechnol 1992, 20:457-462.
18. Sakai Y., Shoji H., Kobayashi T., et al. New extracorporeal blood perification devices for critical care medicine under development. Ther Plasmapheresis 1993, 12:837-842.
19. Boomer J.S., To K., Chang K.C., et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011, 306:2594-2605.
20. Ronco C. The immunomodulatory effect of extracorporeal therapies in sepsis: a reconciliation of three theories. Int J Artif Organs 2007, 30:855-857.
21. Shehep J.L., Flynn P.M., Barrett F.F., et al. Serial quantification of endotoxemia and bacteremia during therapy for Gram-negative bacterial sepsis. J Infect Dis 1988, 157:565-568.
22. Takeshita S., Nakatani K., Tsujimoto H., et al. Detection of circulating lipopolysaccharide-bound monocytes in children with Gram-negative sepsis. J Infect Dis 2000, 182:1549-1552.
23. Pöschl J.M., Leray C., Ruef P., et al. Endotoxin binding to erythrocyte membrane and erythrocyte deformability in human sepsis and in vitro. Crit Care Med 2003, 31:924-928.
24. Nishibori M., Takahashi H.K., Katayama H., et al. Specific removal of monocytes from peripheral blood of septic patients by polymyxin B-immobilized filter column. Acta Med Okayama 2009, 63:65-69.
25. Spielvogel A.R. An ultrastructural study of the mechanisms of platelet-emdotoxin interaction. J Exp Med 1967, 126:235-250.
26. Oishi K., Miura-Kimura Y., Miyasho T., et al. Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosis. Cytokine 2013, 61:84-89.
27. Dixon R.A., Chopra I. Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Esherichia coli. J Antimicrob Chemother 1986, 18:557-563.
28. Sampson T.R., Liu X., Schroeder M.R., et al. Rapid killing of Acinetobacter. Antimicrob Agents Chemother 2012, 56:5642-5649.
29. Maruyama Y., Yoshida H., Uchino S., et al. Nafamostat mesilate as an anticoagulant during continuous veno-venous hemodialysis: a three-year retrospective cohort study. Int J Artif Organs 2011, 34:571-576.